Scientific Chair: Mustafa Nuri Yenerel (İstanbul University, Turkey) Mustafa Çetiner (Koç University, İstanbul)
Title Presenter Name
A Novel Marker CD317 in Patients with CD34 Negative B-Cell Acute Lymphoblastic Leukemia Zehra  Narli Ozdemir
Whole Genome Expression Profiling at Diagnosis Predicts Relapse in Childhood Acute Lymphoblastic Leukemia Khusan   Khodzhaev
Comparıson Of Consolıdatıon Strategıes in Acute Myeloıd Leukemıa: Standard Chemotherapy Vs Autologous Hematopoıetıc Stem Cell Transplantatıon Asena  Dikyar
Post Remission Treatment Score for Predicting the Survival in Acute Myeloid Leukemia : Single Centre Experience Elifcan  Aladag
Long Term Follow up of Idiopathic Cytopenia of Undetermined Significance (ICUS), Clonal Cytopenia of Undetermined Significance (CCUS) Towards Myelodysplastic Syndrome (MDS) Elif Gülsüm Ümit
Determination of Therapeutic Potential of Luteolin for Acute Lymphoblastic Leukemia Cells Sevim  Beyza Gürler
Scientific Chair: Taner Demirer (Ankara University, Turkey), Levent Ündar (Akdeniz University, Turkey)
Title Presenter Name
Exosomal Dna From Plasma Of Patıents Wıth Dlbcl: Comparıson Dna Methylatıon Patterns Of Ezh2-Target Genes Of Exosomes And Matchıng Prımary Tumor Tıssue İkbal Cansu Barış
Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of MIPI: Single Center Experience Güldane  Cengiz Seval
Leukapheresis Reduces 4-Week Mortality in Acute Myeloid Leukemia Patients with Hyperleukocytosis – a Retrospective Study from a Tertiary Center Güldane  Cengiz Seval
Hodgkın Lymphoma In The Elderly: A Retrospectıve Multıcenter Study By Turkısh Socıety Of Hematology, Lymphoma Academy Olga Meltem Akay
Circulating MicroRNA-125a as a Potential Serum Biomarker for Diffuse Large B-Cell Lymphoma Mohammad  Ahmadvand
The Correlatıon Between Interım Imagıng Results and Dısease Prognosıs of Patients with Hodgkın and Dıffuse Large B Cell Lymphoma: Sıngle Center Experıence Esra  Erpek
Scientific Chair: Tülin Tuğlular( Marmara University, Turkey), Jelana Bila(University of Belgrade, Serbia)
Title Presenter Name
Myth or Reality? The Frequency and Significance of Double Hit or Triple Hit Multiple Myeloma at a Single Center in Northwestern Turkey Mehmet  Baysal
The Comparıson of The Relatıonshıp Between Polyneuropathy Frequency and Clınıcal and Laboratory Fındıngs in Multıple Myeloma Cases Aysun  Senturk Yikilmaz
Pre-Transplant Hemoglobin and Serum Creatinine Levels Correlate with Progression Free Survival in Myeloma Patients Undergoing Autologous Stem Cell Transplantation Guldane  Cengiz Seval
Retrospective Evaluation of Immunomudulatory Agents Response and Side Effects in Relapsed Refractoy Myeloma Patients: Real Life Experience Yaşa Gül Mutlu
Collection of Stem Cells  ≥ 5.0 x 10e6/of Body Weight in One Day in Multiple Myeloma in The Process of Autologous Stem Cell Transplantation Alma  Sofo Hafizovic
Can Autologous Stem Cell Transplantation Abrogate The Poor Prognosis Associated with High LDH? Guldane  Cengiz Seval
Scientific Cahir: Hannan Hamed(Ain Shams University, Cairo),  Ahmad Ibrahim(Arab University, Beirut)
Title Presenter Name
An Adaptive Phenotypic Shift Leads to TKI Resistance by Acquisition of Leukemic Stem Cell-Like Properties in CML Cells Zeynep  Yüce
Long Noncodıng Rna Hotaır is a New Potentıal Bıomarker  for Chronıc Myeloıd Leukemıa (Cml) Not for Acute Myeloıd Leukemıa (Aml) in Turkısh Patıents Esma Bentli
Vancomycın Resıstant Enterococcı Colonızatıon, Predısposıng Factors for Infectıon and Prognostıc Factors in Patıents wıth Febrıle Neutropenıa Tugcan  Alp Kırkızlar
Epıdemıology of Chronıc Myeloıd Leukemıa in Azerbaıjan Chingiz  Asadov
Which Markers Should the Used for Chronic Lymphocytic Leukemia Scoring System by Immunophenotyping ? Mehmet  Sezgin Pepeler
Mersin University Last Decade Experience with Myelofibrosis Berrin Balık Aydın